产品说明书

GOT1 inhibitor-1

Print
Chemical Structure| 732973-87-4 同义名 : -
CAS号 : 732973-87-4
货号 : A1352619
分子式 : C19H19ClN4O
纯度 : 99%+
分子量 : 354.833
MDL号 : MFCD31933835
存储条件：

粉末 Sealed in dry,2-8°C

液体 -20°C:3-6个月-80°C:12个月
溶解度 :

DMSO: 120 mg/mL(338.19 mM)，配合低频超声助溶，注意：DMSO长时间开封后，会吸水并导致溶解能力下降，请避免使用长期开封的DMSO
动物实验配方：
生物活性
描述 Pancreatic ductal adenocarcinoma (PDAC) tumors are dependent upon a metabolic pathway involving aspartate aminotransferase 1, also known as glutamate-oxaloacetate transaminase 1 (GOT1), for the maintenance of redox homeostasis and sustained proliferation. GOT1 inhibitor 2c is a non-covalent GOT1 inhibitor with IC50 of 8.2 μM[2].
实验方案
1mg 5mg 10mg

1 mM

5 mM

10 mM

2.82mL

0.56mL

0.28mL

14.09mL

2.82mL

1.41mL

28.18mL

5.64mL

2.82mL
参考文献

[1]Anglin J, Zavareh RB, Sander PN, Haldar D, Mullarky E, Cantley LC, Kimmelman AC, Lyssiotis CA, Lairson LL. Discovery and optimization of aspartate aminotransferase 1 inhibitors to target redox balance in pancreatic ductal adenocarcinoma. Bioorg Med Chem Lett. 2018 Sep 1;28(16):2675-2678. doi: 10.1016/j.bmcl.2018.04.061. Epub 2018 Apr 27. PMID: 29731362; PMCID: PMC6119644.

[2]Anglin J, et al. Discovery and optimization of aspartate aminotransferase 1 inhibitors to target redox balance in pancreatic ductal adenocarcinoma. Bioorg Med Chem Lett. 2018 Sep 1;28(16):2675-2678